Vol. 3, No. 10
October, 2004

Jerry Bylander, Editor  jerryby@cableone.net

FEATURE ARTICLES

The Director's Column

What the doctor forgot to tell you and you forgot to ask

 The new medical paradigm seems to be that the patient works together with his physician to develop the therapy once the disease is diagnosed.  This approach seems to assume the patient is as informed as his doctor, and which underlines the need for the internet search and the support group visit.  It also reduces the amount of time the doctor must spend with the patient planning the treatment, since the patient is assumed to be well informed.  And if you are not, it is your responsibility anyway.

Some examples spring to mind.  Many of us expect to be incontinent after therapy for prostate cancer.  But in a great many cases, neither the nurse or the doctor explains the exercises required to reestablish continence.  Also after a period of healing, it can be important to use the vacuum device regularly to reestablish the erection where possible and to achieve better blood flow to the penis.  You probably won't be told this.  In the event the shots or Viagra fail to establish erectile function, you may want an implant.  In the event of failure to achieve continence you also may want ureter valve prosthesis.  In the rare event you learn about these options, you may have trouble finding a surgeon.  Again there are our members who can help.

If your prostate cancer is not cured by radiation or surgery or it is too far advanced for these therapies, you may be put on androgen deprivation therapy (AKA hormonal therapy and is chemical castration).  You probably will not be told that physical castration is hundreds to thousands of times cheaper and just as effective as Lupron injections or Casodex pills.  You will be told to expect hot flashes.  You may be told to expect muscle loss, osteoporosis, and breast growth.  You may even be told to do load bearing exercises to reduce bone loss.  You will not in almost all cases, or even all cases, be advised of the psychological consequences of castration or chemical castration.  While castration has the advantage of slowing beard growth, say sayonara to sexual desire.  Also the reversion to 98 pound weakling status, we were familiar with when we were preteens, is threatening to our self image of manhood.  That is we become a boy again, albeit an experienced boy.  These factors can have as great an effect as a the death of loved one although the circumstances are quite different.  Your doctor probably can't help you here, since he has no direct experience with these kinds of problems and also is not trained in these areas.  Again here is where your support group can come into play, but with the caveat that only a licensed psychologist or other mental health professional will be able to help beyond our initial "hand holding" kind of support.

Please plan to investigate the unexpected consequences of your therapy, so you can plan in advance to deal with them.  When you don't here is what I told one lady complaining bitterly about the outcomes of her therapy.   We were at an MD Anderson Network meeting and she had to place a finger over her throat and use a buzzer to speak.  After listening at some length to her regrets expressed to the MDA psychologist after our meeting, I told her she must accept the consequences of her decision and get on with her life.  She was still a beautiful woman with a great personality and now needed to move on.


Remember our meetings are always on the third Tuesdays of every other month at 7:00 pm at the Senior Health Center on Calais Drive off Gallagher road in Sherman Texas, behind the TCOG Tower. 
See you at the October meeting.  Jerry Bylander 

Back to Top

Next Meeting


Date: Tuesday Evening, September 21, 2004
Location:  
Center, Wilson N. Jones North Campus, South Entrance, 3305 Calais

6:30 PM - Social & Coffee
7:00 PM - Program

Date and Time:  Tuesday, October 19, 2004  6:30 pm - Social Hour  7:00 pm - Program
Location:  Texas Cancer Center-Sherman, 2800 Highway 75N (and Cornerstone Road).        

Topic:
  "Do You Plan Radiation Therapy in Place of Surgery?"

Speaker:  Dr. Hebert, Texas Cancer Centers, Sherman and Denison

Program:   Dr. Hebert is always popular as speaker and will bring us her view points.  She is a long time speaker at our meetings, and is well versed in the latest treatments for prostate cancer.  In this meeting, she will walk us through the Cancer Center’s graded and shaped beam machine which is designed to minimize damage to surrounding tissue.  She also will discuss your options and the suitability of radiation for you against the option of surgery.

Back to Top

Last Meeting: "What are  your  questions and  Concerns  About  Prostate  Cancer"
Date & Time: Tuesday, September 21,  2004, 7:00 PM
Place: Wilson N. Jones, North Campus
Attendance: approximately 25 attendees

 Speaker:  Dr. Larry Barker, Texas Cancer Centers, Sherman and Denison.
Program:   This was one of our best meetings so far, and brought up to date on recent advances in the treatment of advanced prostate cancer.  Several newly diagnosed attendees received helpful literature on how to choose suitable therapy.

The meeting adjourned about 9 PM.

Henri Plunkett, Program Chair/by the Editor

Back to Top

Other Important Events
Your organization's meetings listed here.  Contact the Editor at jerryby@cableone.net

Back to Top

Editor's Notes
Why I Read the Newsletter

I hope most everyone is familiar with the terms, PSA, DRE, Gleason score or sum. To review: PSA is short for prostate specific antigen (an antigen is any source that initiates an immune response). Second, DRE is digital (finger) rectal exam. This exam consists of a doctor simply feeling the prostate through the anus and feeling for lumps, rigidity or enlargement. THIS IS A HIGHLY SUBJECTIVE EXAM, IN THAT, ONE CAN ONLY FEEL TWO OF THE THREE LOBES OF THE PROSTATE (ONE IS ON TOP), AND NATURALLY MOST EVERY PHYSICIAN'S OPINION WILL VARY. Third, the Gleason score is the key part of a  simple pathological analysis is are necessary to allow you and your doctor to determine your therapy choices.  You will partly make your choice of surgical  removal or radiation or androgen deprivation or simply doing nothing based on the Gleason score. 
HERE IS INFORMATION YOUR DOCTOR DOESN'T TELL YOU.  First, PSA results vary from laboratory to laboratory.  You should make sure your specimen goes to the same lab consistently (or after several PSA's calibrate the offset between labs. Ed.).  Second, DRE's are like previously noted (subjective), however I am quite sure your doctor will assure that he is highly competent is this exam, since he does many and then sees the outcomes. Third, the Gleason score  is derived, first from that biopsy tissue when you did your spring loaded biopsy.  It was submitted to a pathologist who reviews and grades these samples. YES, ONCE AGAIN THIS SYSTEM OF ANALYSIS IS ALSO SUBJECTIVE.  Although it too is based on experience, and in difficult cases a second pathologist opinion, the pathologist generally does not have the advantage of knowing the outcomes of his diagnosis. And to get to the point, since major decisions of treating the cancer usually will rest on this test alone, should a pathologist misgrade the score, a chosen therapy based on that determination is not the desired approach. Many great physicians in the field of prostate cancer specialization will ask or request a second opinion on the Gleason grading system by an expert in the field to insure their recommendations are likely more accurate.  (Likely only since much of prostate cancer diagnosis is based on averages--see an earlier newsletter for a discussion.)  A second opinion costs around three hundred dollars, and most insurance carriers will pay for the second opinion. Take a note here, insurance companies don't pay for anything unless they deem it beneficial for them.  They must think that a second opinion is a good idea. Good luck and see you at the October meeting..........henri plunkett

Survey Results from the Local Urologists and Oncologists

I polled the seven local urologists and two oncologists that I was aware of.  The oncologists and one urologist were willing to continue to speak.  One other urologist commented that he was in favor of our continuing, but felt there was no new information given at our meetings (he never attends).

Preliminary Survey Results from our Members

We sent out more than 125 surveys.  

Jerry Bylander, Editor

Back to Top